{"id":14056,"date":"2011-08-17T16:30:00","date_gmt":"2011-08-17T14:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/le-multinazionali-del-farmaco-travolte-dalla-liberta-di-facebook\/"},"modified":"2011-08-17T16:30:00","modified_gmt":"2011-08-17T14:30:00","slug":"le-multinazionali-del-farmaco-travolte-dalla-liberta-di-facebook","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/le-multinazionali-del-farmaco-travolte-dalla-liberta-di-facebook\/","title":{"rendered":"The drug multinationals overwhelmed by the freedom of Facebook"},"content":{"rendered":"

August 17, 2011<\/p>\n

<\/font><\/font><\/span><\/p>\n

The social network opens the message boards of fan pages. And they delete them<\/p>\n

<\/font><\/font><\/p>\n

As Facebook decided to gradually open pharmaceutical company pages to the public allowing users to comment this week, a number of companies decided to close them.<\/p>\n

<\/font><\/font><\/p>\n

FREEDOM OF FACEBOOK \u2013 The Washington Post tells us that Facebook has changed the policy which allowed pharmaceutical companies to keep the walls of fan pages closed and did not allow comments. Pages focused on the companies themselves and the disease or patient communities are now open for comment, while those targeting a specific product prescription continue to be closed. Companies fear that open bulletin boards could lead to the reporting of side effects, the promotion of unlabelled drugs or inappropriate claims \u2013 which could cause concern to government regulators. Like other Facebook users, businesses can delete comments once they've been posted.<\/p>\n

<\/font><\/font><\/p>\n

Sanofi, which has pages about diabetes and whooping cough and a company page, hasn't reported any particular problems so far. Pfizer also had no problems, spokesman Andrew Widger said.  <\/span>Other companies have instead decided to remove the pages in the last couple of days.  <\/span>Amgen, which previously planned to keep its cancer page, then removed it on Monday. The company sells iNeulasta, Neupogen and Vectibix.  <\/span>\u201cWe are still working on implementing a comment moderation,\u201d spokeswoman Christine Regan said. Amgen has been working with Facebook, but "we're not comfortable with the solutions they've suggested," he added.<\/p>\n

<\/font><\/font><\/p>\n

Bayer shut down the "Strong at Heart" page, which had more than 26,000 likes. Instead, the company wants to keep the "I Am ProHeart," which has more than 49,000 likes.  <\/span>\u201cWe have monitoring and response procedures already in place for the page,\u201d spokeswoman Anne Coiley said. Purdue Pharma and Johnson & Johnson have also closed their pages.<\/p>\n

<\/font><\/font><\/p>\n

August 17, 2011 hours <\/font>18:27<\/font><\/span><\/strong><\/a>   \"\"<\/span><\/font><\/span><\/p>","protected":false},"excerpt":{"rendered":"

17 agosto 2011 Il social network apre le bacheche delle pagine fan. E loro le cancellano Non appena Facebook ha deciso di aprire gradualmente le pagine delle industrie farmaceutiche al pubblico permettendo agli utenti di commentare questa settimana, una serie di aziende ha deciso di chiuderle. LA LIBERTA’ DI FACEBOOK – Racconta il Washington Post …<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-14056","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/14056","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=14056"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/14056\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=14056"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=14056"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=14056"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}